Cargando…
Estradiol and Estrogen Receptor Agonists Oppose Oncogenic Actions of Leptin in HepG2 Cells
Obesity is a significant risk factor for certain cancers, including hepatocellular carcinoma (HCC). Leptin, a hormone secreted by white adipose tissue, precipitates HCC development. Epidemiology data show that men have a much higher incidence of HCC than women, suggesting that estrogens and its rece...
Autores principales: | Shen, Minqian, Shi, Haifei |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Public Library of Science
2016
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4794158/ https://www.ncbi.nlm.nih.gov/pubmed/26982332 http://dx.doi.org/10.1371/journal.pone.0151455 |
Ejemplares similares
-
Effects of Estrogen and Estrogen Receptors on Transcriptomes of HepG2 Cells: A Preliminary Study Using RNA Sequencing
por: Shen, Minqian, et al.
Publicado: (2018) -
A Multi-Omics Study Revealing the Metabolic Effects of Estrogen in Liver Cancer Cells HepG2
por: Shen, Minqian, et al.
Publicado: (2021) -
Glucocorticoid Receptor β Overexpression Has Agonist-Independent Insulin-Mimetic Effects on HepG2 Glucose Metabolism
por: Sepúlveda-Quiñenao, Claudia, et al.
Publicado: (2022) -
Effect of Genistein and 17-β Estradiol on the Viability and Apoptosis of Human Hepatocellular Carcinoma HepG2 cell line
por: Sanaei, Masumeh, et al.
Publicado: (2017) -
Effects of 2-Methoxyestradiol, a Main Metabolite of Estradiol on Hepatic ABCA1 Expression in HepG2 Cells
por: Ibata, Tomohiro, et al.
Publicado: (2022)